ACE Convergence Acquisition Corp.

Another wrapper around a report the corpus already holds - the fifth supplement to one prospectus in under three months, which is what makes 424B3 the highest-volume form here without being the most informative one. What it does record is the terminal state of the securities the SPAC created: a warrant struck at $11.50 quoted at $0.023, and the common stock at $0.2517, both on 3 August 2023. Flagged for review because registrant, form and materiality all differ from what this row assumes.

Those notes sit where the numbers are least settled. Financing is given as 10,200,000 shares of New Tempo common stock to PIPE investors, $200.0 million of 15.5% Convertible Notes from Tor and OCM and an ACE Convertible Note of $20.0 million, for aggregate gross proceeds of $322.0 million — against a Minimum Available Acquiror Cash Amount of $320.0 million, a condition held for Tempo's sole benefit. The trust totalled approximately $230.2 million at December 31, 2021, and ACE's units, Class A ordinary shares and warrants closed at $10.14, $9.92 and $0.58.

The cover is a prospectus for 80,759,726 shares of common stock and 14,471,303 warrants of the domesticated entity, and it carries no calculation of registration fee table at all — the fee information is not on the face of the document, so nothing here supports a fee-derived transaction value. The proposals go to an extraordinary general meeting rather than a special meeting of stockholders, ACE still being a Cayman Islands exempted company when the vote is taken, and the transaction was approved by the disinterested members of the board rather than the full board.

Only part of that total is consideration. The 28,750,000 shares at $9.98 and 11,500,000 warrants at $1.23 are ACE's own public and founder shares and public warrants converting one-for-one in the Domestication. The Tempo line of 55,973,271 shares — 41,705,814 merger shares including up to 7,500,000 earnout shares, plus 14,267,458 option shares — carries an aggregate price of only $186.58 because Rule 457(f)(2) values a private target at one-third of aggregate par. The 9,400,000 Advanced Circuits shares are priced at $31.08, the NYSE high/low of CODI, the seller's listed parent.

The consideration is stated on its own terms: 169,355,555 shares of New Achronix common stock at a deemed value of $10.00 per share plus $50,000,000 in cash, which the filing says represents a pre-transaction equity value for Achronix of approximately $1.7 billion. The cover's warrant figure does not match the body: the cover registers 11,500,000 redeemable warrants, while the text states the proxy statement/prospectus covers 18,100,000 New Achronix warrants to be issued in the Domestication alongside 28,750,000 shares. Both ACE share classes convert one-for-one.

The three lines are priced on different bases and only one is a market price: the 28,750,000 carried-over shares and 11,500,000 warrants are valued from Nasdaq trading on February 5, 2021, while the 169,355,555 merger shares carry an aggregate offering price of just $56,452, because Achronix is private with an accumulated deficit and Rule 457(f)(2) uses one-third of par value. Those 169,355,555 shares are 148,268,793 issued in the merger plus 21,086,762 reserved for converted Achronix options and restricted stock units outstanding at March 31, 2021.